AngioDynamics (NASDAQ:ANGO) Updates FY 2025 Earnings Guidance

AngioDynamics (NASDAQ:ANGO) issued an update on its FY 2025 earnings guidance on Wednesday morning. The company provided earnings per share guidance of -0.380–0.340 for the period, compared to the consensus earnings per share estimate of -0.400. The company issued revenue guidance of $282.0 million-$288.0 million, compared to the consensus revenue estimate of $283.9 million.

Analysts Set New Price Targets

Several research analysts have weighed in on the stock. Canaccord Genuity Group lowered their price target on shares of AngioDynamics from $13.00 to $12.00 and set a “buy” rating on the stock in a report on Friday, October 4th. HC Wainwright reiterated a “buy” rating and set a $14.00 target price on shares of AngioDynamics in a research note on Tuesday, December 10th.

AngioDynamics Stock Performance

NASDAQ:ANGO opened at $9.40 on Wednesday. AngioDynamics has a 52 week low of $5.26 and a 52 week high of $9.63. The firm’s 50-day simple moving average is $7.82 and its 200 day simple moving average is $7.27. The firm has a market cap of $381.96 million, a price-to-earnings ratio of -1.54 and a beta of 0.59.

AngioDynamics (NASDAQ:ANGO) last issued its quarterly earnings results on Wednesday, January 8th. The medical instruments supplier reported ($0.04) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.11) by $0.07. AngioDynamics had a negative return on equity of 5.86% and a negative net margin of 83.95%. Sell-side analysts anticipate that AngioDynamics will post -0.41 EPS for the current year.

About AngioDynamics

AngioDynamics, Inc, a medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. The company offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium.